Facetten
Zugriff
Einrichtung
Medientyp
- Text 3
Karte
Erscheinungsjahr
Autor/in
- Semiglazov, Vladimir
- Barrett-Lee, Peter 1
- Chan, Arlene 1
- Ciruelos, Eva 1
- Clark, Emma 1
- alle zeigen
Sprache
- Englisch 3
3 Einträge gefunden
-
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
- Swain, Sandra M
- Miles, David
- Kim, Sung-Bae
- Im, Young-Hyuck
- Im, Seock-Ah
- Semiglazov, Vladimir
- Ciruelos, Eva
-
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer):an open-label randomised study
- Pivot, Xavier
- Gligorov, Joseph
- Müller, Volkmar
- Barrett-Lee, Peter
- Verma, Sunil
- Knoop, Ann
- Curigliano, Giuseppe
-
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.
- Eiermann, Wolfgang
- Pienkowski, Tadeusz
- Crown, John
- Sadeghi, Saeed
- Martin, Miguel
- Chan, Arlene
- Saleh, Mansoor